Stryker Corp forecast 2024 profit above Wall Street estimates on Tuesday, banking on a post-pandemic pick-up in volume for certain surgical procedures at hospitals to drive sales for its medical and s
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Stryker (SYK), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the qua
The robotics sector is on the brink of an extraordinary boom, with MarketsandMarkets projecting its value to skyrocket from $17.0 billion in 2023 to $32.5 billion by 2028. This steep ascent is just th
Jim Lebenthal, chief equity strategist at Cerity Partners, Jenny Harrington, Gilman Hill Asset Management CEO, Joe Terranova, senior managing director at Virtus Investment Partners, and Brenda Vingiel
Here are three stocks in the health care sector that could provide further upside potential based on their improving technical characteristics.
One very promising and innovative area of technology is robotics. Finding the best robotics stocks is not only a stroke of luck for savvy investors looking to exploit this highly-growing industry.
Stocks like Medtronic (MDT), Stryker (SYK) and NVIDIA (NVDA) are likely to benefit from the rising prospects of Generative AI in healthcare.
Portage, Michigan, Jan. 05, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will report financial results for fourth quarter and full year 2023 on Tuesday, January 30, 2024.  A press re
Stryker (SYK) continues to benefit from strength in the robotic arm-assisted surgery platform, Mako, and its broad product portfolio.
Investors interested in Medical - Products stocks are likely familiar with Haemonetics (HAE) and Stryker (SYK). But which of these two stocks is more attractive to value investors?
Stryker (SYK) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Investors with an interest in Medical - Products stocks have likely encountered both Haemonetics (HAE) and Stryker (SYK). But which of these two companies is the best option for those looking for unde
Stryker (SYK) continues to benefit from strength in the robotic arm-assisted surgery platform, Mako, and its broad product portfolio.

Why Stryker Is An Awesome Healthcare Compounder

05:11pm, Thursday, 30'th Nov 2023
Stryker boasts a 13.7% annual return, consistent dividends, and innovation-driven market dominance. Stryker's focus on Orthopaedics and Spine, coupled with a resilient financial position and strategic
Stryker Corporation (NYSE:SYK ) 6th Annual Evercore ISI HealthCONx Conference November 29, 2023 1:20 PM ET Company Participants Glenn Boehnlein - CFO Jason Beach - Head, IR Conference Call Participant
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE